Literature DB >> 12195782

Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus.

C A A Silva1, M M Leal, C Leone, V P Simone, A D Takiuti, M I Saito, M H B Kiss.   

Abstract

The authors analysed the gonadal function and age of menarche of 23 female adolescents and young women with SLE, and correlated these with clinical, SLEDAI and therapeutic parameters. The presence of one or more clinical and laboratory parameters defined normal gonadal function: normal menstrual cycles with or without dysmenorrhea; elevated cervical mucus length; normal levels of plasma FSH, LH, estradiol, progesterone, prolactin and testosterone; normal urinary hormonal cytology; serial pelvic ultrasound compatible with ovulatory pattern; and present or previous pregnancy. The mean age of menarche (13.5 +/- 1.4 years) was greater than that found among 2578 healthy Brazilian adolescents (12.5 +/- 1.3 years; P = 0.0002). The delay in menarche correlated with an increase in the duration of the disease (P = 0.0085) and the cumulative dose of prednisone (P = 0.0013) used until the appearance of the menarche. The mean phase length in SLE was 31.5 +/- 10.3. Sixteen female (70%) patients showed normal and seven (30%) abnormal gonadal function. Gonadal function was not correlated with parameters of SLE. These results suggest that the patients of this study reach adulthood with a high chance of fertility.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195782     DOI: 10.1191/0961203302lu219oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  16 in total

1.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

2.  Pregnancy rates and perinatal outcomes in women with systemic lupus erythematosus: data from the Korean national health claims database.

Authors:  Young Bin Joo; Ki-Jo Kim; Kyung-Su Park; Yune-Jung Park
Journal:  Clin Rheumatol       Date:  2020-11-12       Impact factor: 2.980

Review 3.  Estrogen and autoimmune disease.

Authors:  Sara E Walker
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 4.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

5.  Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.

Authors:  Jill P Buyon; Mimi Y Kim; Marta M Guerra; Carl A Laskin; Michelle Petri; Michael D Lockshin; Lisa Sammaritano; D Ware Branch; T Flint Porter; Allen Sawitzke; Joan T Merrill; Mary D Stephenson; Elisabeth Cohn; Lamya Garabet; Jane E Salmon
Journal:  Ann Intern Med       Date:  2015-08-04       Impact factor: 25.391

6.  Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea.

Authors:  Clovis A Silva; Maria E J Deen; Marilia V Febrônio; Sheila K Oliveira; Maria T Terreri; Silvana B Sacchetti; Flavio R Sztajnbok; Roberto Marini; Maria V Quintero; Blanca E Bica; Rosa M Pereira; Eloisa Bonfá; Virginia P Ferriani; Teresa C Robazzi; Claudia S Magalhães; Maria O Hilário
Journal:  Rheumatol Int       Date:  2010-03-21       Impact factor: 2.631

7.  Penile alterations with severe sperm abnormalities in antiphospholipid syndrome associated with systemic lupus erythematosus.

Authors:  Carlos Nobre Rabelo-Júnior; Eloisa Bonfá; Jozélio F Carvalho; Marcello Cocuzza; Osmar Saito; Carmita H Abdo; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2012-09-11       Impact factor: 2.980

Review 8.  Therapeutic amenorrhea in patients at risk for thrombocytopenia.

Authors:  Meredith K Martin-Johnston; Olanma Y Okoji; Alicia Armstrong
Journal:  Obstet Gynecol Surv       Date:  2008-06       Impact factor: 2.347

9.  Diminished ovarian reserve in Behçet's disease patients.

Authors:  Andrea R S Mont'Alverne; Lucas Y S Yamakami; Célio R Gonçalves; Edmund C Baracat; Eloisa Bonfá; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2014-05-31       Impact factor: 2.980

10.  Non-steroidal anti-inflammatory drug induces luteinized unruptured follicle syndrome in young female juvenile idiopathic arthritis patients.

Authors:  Renato B Tomioka; Gabriela R V Ferreira; Nadia E Aikawa; Gustavo A R Maciel; Paulo C Serafini; Adriana M Sallum; Lucia M A Campos; Claudia Goldestein-Schainberg; Eloisa Bonfá; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2018-07-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.